Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).

This study is one of the largest to date to assess brain growth in opioid-exposed fetuses in utero. 

The results of a new trial offer “much needed progress” in the treatment of PD, experts involved in the study suggested. 

When exam volumes increase, so too does the risk of diagnostic errors in interpretations, many of which can be clinically significant.

The treatment has the potential to “extend lifespans and improve quality of life” in patients with brain cancer, according to experts at UC San Diego Health. 

A new analysis revealed that children are at a 15% increased risk of an emotional or behavioral problem if they have experienced a mild TBI.

“Results of this case-control study suggest that even for maximum univariate biological differences, deviations between patients with MDD and healthy controls were remarkably small," experts shared in JAMA Psychiatry.

A new paper published in Radiology details an analysis of 3-T, 5T and 7T MRI to determine which system could achieve the best intracranial vascular image quality.